$4m balance sheet improvement with bond conversion

Summary by AI BETAClose X

Renalytix plc announced a $4 million balance sheet improvement due to the conversion of approximately $4 million of non-amortizing senior convertible bonds. This conversion involves the issuance of 31,650,034 ordinary shares to the Convertible Bond Investor at 9.5 pence per share. The conversion is expected to save up to $1.4 million in accrued interest over the loan's remaining life and improve the company's debt-to-equity ratio. Following admission, the company's total issued share capital will be 437,018,680 Ordinary Shares of £0.0025 each.

Disclaimer*

UK 100

Latest directors dealings